[HTML][HTML] Humanising the mouse genome piece by piece

F Zhu, RR Nair, EMC Fisher, TJ Cunningham - Nature communications, 2019 - nature.com
To better understand human health and disease, researchers create a wide variety of mouse
models that carry human DNA. With recent advances in genome engineering, the targeted …

Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders

S Rivera, L García-González, M Khrestchatisky… - Cellular and Molecular …, 2019 - Springer
As life expectancy increases worldwide, age-related neurodegenerative diseases will
increase in parallel. The lack of effective treatment strategies may soon lead to an …

[HTML][HTML] Cell-autonomous and non-cell-autonomous pathogenic mechanisms in Huntington's disease: insights from in vitro and in vivo models

J Creus-Muncunill, ME Ehrlich - Neurotherapeutics, 2019 - Elsevier
Huntington's disease (HD) is an autosomal dominant disorder caused by an expansion in
the trinucleotide CAG repeat in exon-1 in the huntingtin gene, located on chromosome 4 …

Dysfunctional striatal dopamine signaling in Huntington's disease

ET Koch, LA Raymond - Journal of neuroscience research, 2019 - Wiley Online Library
Dopamine signaling in the striatum is critical for a variety of behaviors including movement,
behavioral flexibility, response to reward and many forms of learning. Alterations to …

[图书][B] Investigating the Dysregulation and Therapeutic Potential of Neuroprotective Stress Response Proteins in Huntington's Disease

JM Rieders - 2019 - search.proquest.com
Huntington's disease (HD) is a fatal, genetic neurodegenerative disease that shares many
features with other common neurological disorders, including early synapse loss. In both …

[引用][C] 亨廷顿病模型进展及展望

张雪艳, 李军, 闫森 - 重庆医科大学学报, 2019

[引用][C] OXIDANT/ANTIOXIDANT IMBALANCES IN HUNTINGTON'S DISEASE

AK Misra, S Singh, PK Sharma, S Ambwani, SK Varma